Gsk nigeria news
Here are some recent news updates from GlaxoSmithKline (GSK) Nigeria:
Recent News
- GSK Nigeria Launches New Respiratory Medicine: GSK Nigeria has launched a new respiratory medicine, Trelegy Ellipta, to help manage chronic obstructive pulmonary disease (COPD) and asthma. (Source: BusinessDay)
- GSK Nigeria Partners with Nigerian Government to Improve Healthcare: GSK Nigeria has partnered with the Nigerian government to improve healthcare services in the country. The partnership aims to strengthen healthcare infrastructure, improve access to medicines, and enhance healthcare worker training. (Source: Vanguard)
- GSK Nigeria Introduces New Vaccine for Meningitis: GSK Nigeria has introduced a new vaccine, Menveo, to help prevent meningitis in Nigeria. The vaccine is recommended for individuals aged 2-55 years and is available in all states of the federation. (Source: ThisDay)
- GSK Nigeria Wins Award for Excellence in Healthcare: GSK Nigeria has won the award for Excellence in Healthcare at the 2022 Nigeria Healthcare Excellence Awards. The award recognizes the company's contributions to improving healthcare in Nigeria. (Source: Leadership)
- GSK Nigeria Launches New Initiative to Improve Maternal and Child Health: GSK Nigeria has launched a new initiative to improve maternal and child health in Nigeria. The initiative aims to reduce maternal and child mortality rates by increasing access to healthcare services and improving healthcare infrastructure. (Source: The Guardian)
Recent Press Releases
- GSK Nigeria Launches Trelegy Ellipta, a New Respiratory Medicine: GSK Nigeria has launched Trelegy Ellipta, a new respiratory medicine that combines three active ingredients to help manage COPD and asthma. (Source: GSK Nigeria Press Release)
- GSK Nigeria Partners with Nigerian Government to Improve Healthcare: GSK Nigeria has partnered with the Nigerian government to improve healthcare services in the country. The partnership aims to strengthen healthcare infrastructure, improve access to medicines, and enhance healthcare worker training. (Source: GSK Nigeria Press Release)
- GSK Nigeria Introduces Menveo, a New Vaccine for Meningitis: GSK Nigeria has introduced Menveo, a new vaccine that helps prevent meningitis in Nigeria. The vaccine is recommended for individuals aged 2-55 years and is available in all states of the federation. (Source: GSK Nigeria Press Release)
Please note that these news updates are subject to change and may not be up-to-date. For the latest news and information on GSK Nigeria, I recommend visiting the company's official website or following reputable news sources.